New antibiotic overcomes antimicrobial mechanisms
Researchers have created a novel molecule, which has an improved ability to bind to bacterial ribosomes, with a completely synthetic system.
List view / Grid view
Researchers have created a novel molecule, which has an improved ability to bind to bacterial ribosomes, with a completely synthetic system.
New immunotherapies may be developed for patients with HCC associated with steatotic liver disease, with TREM1 suggested as a target.
Single-cell RNA analysis provides an immunological explanation for the association between periodontitis and diabetes mellitus.
Researchers have discovered the role of two genes that protect mammalian germ cells, which could influence male fertility.
Using tumour organoids, researchers identified that overexpression of Engrailed-1 blocked genes associated with natural cell death.
For the first time, researchers reveal the involvement of OXT in object recognition memory through the supramammillary nucleus.
Researchers have created dual-targeted CARs, which performed better than single-targeted CARs in both in vivo and in vitro experiments.
Researchers have identified key differences between HSV-1 and HSV-2 and have developed monoclonal antibodies that could treat neonatal infections.
By studying the molecular cell states within transplanted paediatric hearts, researchers have unlocked new treatment strategies.
Low-dose positron emission mammography (PEM) has a high sensitivity for detecting cancer and reduces the likelihood of false positives.
Researchers have developed a computational analysis tool which will improve patient stratification and enable personalised medicine.
Scientists have discovered that increasing the levels of the CDKL2 enzyme could stop CDD symptoms developing or worsening.
Disrupting the mechanism that EGFR-driven lung adenocarcinoma uses to alter macrophages’ lipid metabolism could inspire new treatments.
A mechanism by which the immune system influences central nervous system function and behaviour has been discovered.
Researchers have discovered potential biomarkers to identify paediatric sepsis progression stage, enabling more targeted treatment.